Details

Autor(en) / Beteiligte

• van Amersfoorth, S. C. M
• Schouls, L. M
• van der Heide, H. G. J
• Advani, A
• Hallander, H. O
• Bondeson, K
• von König, C. H. W
• Riffelmann, M
• Vahrenholz, C
• Guiso, N
• Caro, V
• Njamkepo, E
• He, Q
• Mertsola, J
• Mooi, F. R

Titel

Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies

Ist Teil von

• Journal of Clinical Microbiology, 2005-06, Vol.43 (6), p.2837-2843

Ort / Verlag

Washington, DC: American Society for Microbiology

Erscheinungsjahr

2005

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Despite the widespread use of pertussis vaccines during the last decades, pertussis has remained an endemic disease with frequent epidemic outbreaks. Currently two types of vaccines are used: whole-cell vaccines (WCVs) and recently developed acellular vaccines (ACVs). The long-term aim of our studies is to assess the effect of different vaccination policies on the population structure of Bordetella pertussis and ultimately on the disease burden in Europe. In the present study, a total of 102 B. pertussis isolates from the period 1998 to 2001 from five European countries (Finland, Sweden, Germany, The Netherlands, and France) were characterized. The isolates were analyzed by typing based on variable number of tandem repeats (VNTR); by sequencing of polymorphic genes encoding the surface proteins pertussis toxin S1 and S3 subunits (ptxA and ptxC), pertactin (prn), and tracheal colonization factor (tcfA); and by fimbrial serotyping. The results reveal a relationship between geographic location and VNTR types, the frequency of the ptxC alleles, and serotypes. We have not observed a relationship between the strain characteristics we studied and vaccination programs. Our results provide a baseline which can be used to reveal changes in the B. pertussis population in Europe in the coming years.